QA: Zevra Therapeutics INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001434647_2024_Zevra_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001434647, Zevra Therapeutics INC

  xvar xval
0 AssetsCurrent 86,938,000
1 IntangibleAssetsNetIncludingGoodwill 73,928,000
2 PropertyPlantAndEquipmentNet 736,000
3 remainder_Assets 10,725,000
4 LiabilitiesCurrent 73,720,000
5 LiabilitiesNoncurrent 7,914,000
6 remainder_Liabilities 28,829,000
7 CostOfGoodsAndServicesSold 2,945,000
8 SellingGeneralAndAdministrativeExpense 50,386,812
9 ResearchAndDevelopmentExpense 36,743,703
10 remainder_Expenses 811,991
11 remainder_Revenues 27,973,963
12 remainder_NetIncome -2,087,568
13 remainder_ComprehensiveNetIncome -156,000
  yvar yval
0 Assets 172,327,000
1 Liabilities 110,463,000
2 Expenses 90,887,506
3 Revenues 27,973,963
4 StockholdersEquity 61,864,000
5 NetIncome -65,001,111
6 ComprehensiveNetIncome -65,079,111
7 BaseVar 201,947,518
8 EconomicCapitalRatiobeforeLimitedLiability 0.494
9 EconomicCapitalRatio 1.88

Edgar->Model Mapping

Feature Distribution

Change over Time